Search results
Harmony Biosciences reports positive pitolisant study results By Investing.com
Investing.com· 3 days agoHarmony Biosciences (NASDAQ: HRMY) has revealed findings from a Phase 2 study indicating that its...
Keymed Biosciences Announces Long-term Efficacy and Safety Data from a Phase III Clinical Trial of...
Clearfield Progress· 6 days agoKeymed Biosciences Inc. (HKEX: 02162) today announced the long-term efficacy and safety data of a Phase III clinical trial of stapokibart injection in patients with moderate-to-severe ...
ASCO 2024: Precede Biosciences assay classifies HER2 and ER status in cancers
Clinical Trials Arena via Yahoo Finance· 5 days agoPrecede Biosciences has announced positive results for its novel liquid biopsy assay, which can...
Keymed reports positive efficacy of stapokibart in Phase III clinical trial
Clinical Trials Arena via Yahoo Finance· 5 days agoKeymed Biosciences has reported long-term efficacy and safety data of a Phase III clinical trial of...
Small Business - The Roanoke-Chowan News-Herald | The Roanoke-Chowan News-Herald
Roanoke-Chowan News-Herald· 3 days agoHARMONY BIOSCIENCES PRESENTS POSITIVE DATA FOR PITOLISANT IN THE TREATMENT OF EXCESSIVE DAYTIME SLEEPINESS AND FATIGUE IN MYOTONIC DYSTROPHY TYPE 1 Phase ...
... Gastric, Colorectal Cancer Studies Why Is Arcus Biosciences Stock Trading Higher Today? - Arcus ...
Benzinga· 5 days agoGilead Sciences and Arcus Biosciences report sustained efficacy and safety in the Phase 2 EDGE-Gastric study for upper GI cancers, showing improved progression-free survival ...
...: Bragar Eagel & Squire, P.C. is Investigating Ventyx Biosciences, Inc. on Behalf of Long-Term...
Morningstar· 5 days agoBragar Eagel & Squire, P.C., a nationally recognized shareholder rights law firm, is investigating potential claims against Ventyx Biosciences, Inc. (NASDAQ: VTYX) on behalf ...
Could vitamin C treat skin cancer? USF study shows promise
WTVT via Yahoo News· 1 day agoAs families get ready to spend more time outside this summer break, Bay Area medical professionals...
Crinecerfont Promising for Congenital Adrenal Hyperplasia
Medscape· 7 days agoCrinecerfont, an investigational oral selective corticotropin-releasing factor type 1 receptor...
Future of Food: Agritech Sector's Efforts to Combat Increasing Global Food Security Threats - Bee...
Benzinga· 4 days agoUSA News Group – The threat of the world's food supply for the future is now being amplified by atomic scientists, calling for the need to act now to ensure global food security and reduce agricultural ...